Page 14 - Telemedicine - Essentials of Virtual Care Delivery Part Two
P. 14
SVMIC Telemedicine: Essentials of Virtual Care Delivery
downloaded from the SVMIC website. If you’re treating new
patients via telemedicine, then the consent should also include
a general consent for treatment.
There are some unique risks to receiving care via telemedicine
that patients should be made aware of as part of obtaining their
consent to treatment. Some of these risks include: an inability to
completely assess the patient’s condition given the diagnostic
limitations of the equipment used, namely the inability to
touch, smell, or physically examine certain areas of the body;
limitations in the equipment or connection which may render
the visit inadequate for remote consultation; and the possibility
that the patient cannot be adequately assessed by telemedicine,
necessitating a referral for in-person treatment. Some states
have specific informed consent requirements including
disclosures of risks specifically associated with telemedicine,
such as equipment failure or privacy breach during the visit.
Additionally, depending on the reason for the encounter, as
well as the medical specialty, there may be other unique risks
and considerations for the telemedicine encounter. Expected
benefits of the telemedicine encounter, such as improved
access to medical care while allowing patients to remain at
home, should also be included as part of the consent.
Obviously given the remote nature of the visit, it’s sometimes
difficult to present the patient with a written form for signature,
but many telemedicine platforms have the capability
of electronically capturing a patient’s consent. During
the pandemic, many states suspended written consent
requirements and allowed verbal consent, as it may be the
only option and is usually considered sufficient under the
circumstances in most jurisdictions.
Page 14